Migraine and other headaches: Associations with Rose angina and coronary heart disease

Neurology

Volumn 63, Issue 12, 2004, Pages 2233-2239

  Rose, K M ^a   Carson, A P ^a   Sanford, C P ^b   Stang, P E ^c   Brown, C A ^d   Folsom, A R ^e   Szklo, M ^f  

^a IL   (United States)

^b NORTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c Galt Associates Inc   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; EPILEPTIC AURA; FEMALE; GENDER; HEADACHE; HUMAN; ISCHEMIC HEART DISEASE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; POISSON DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; ROSE ANGINA; SOCIAL ASPECT;

EID: 11144253505     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000147289.50605.DC     Document Type: Article

References (49)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-69.
2. Cook NR, Evans DA, Funkenstein HH, et al. Correlates of headache in a population-based cohort of elderly. Arch Neurol 1989;46:1338-1344.
3. Russell MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996;16:239-245.
4. Roh JK, Kim JS, Ahn YO. Epidemiologic and clinical characteristics of migraine and tension-type headache in Korea. Headache 1998;38:356-365.
5. Devoto M, Lozito A, Staffa G, D'Alessandro R, Sacquegna T, Romeo G. Segregation analysis of migraine in 128 families. Cephalalgia 1986;6: 101-105.
6. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. Br Med J 1995;311:541-544.
7. Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache 2004;44:53-64.
8. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002;346:257-270.
9. Wolff HG. Headache and other head pain. New York: Oxford University Press, 1963.
10. Lauritzen M, Skyhoj Olsen T, Lassen NA, Paulson OB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983;13:633-641.
11. Olsen TS, Lassen NA. Blood flow and vascular reactivity during attacks of classic migraine-limitations of the Xe-133 intraarterial technique. Headache 1989;29:15-20.
12. Andersen AR, Friberg L, Olsen TS, Olesen J. Delayed hyperemia following hypoperfusion in classic migraine. Single photon emission computed tomographic demonstration. Arch Neurol 1988;45:154-159.
13. Mitchell P, Wang JJ, Currie J, Cumming RG, Smith W. Prevalence and vascular associations with migraine in older Australians. Aust NZ J Med 1998;28:627-632.
14. Leviton A, Malvea B, Graham JR. Vascular diseases, mortality, and migraine in the parents of migraine patients. Neurology 1974;24:669-672.
15. Chen TC, Leviton A, Edelstein S, Ellenberg JH. Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol 1987;44:1024-1028.
16. Cook NR, Bensenor IM, Lotufo PA, et al. Migraine and coronary heart disease in women and men. Headache 2002;42:715-727.
17. Sternfeld B, Stang P, Sidney S. Relationship of migraine headaches to experience of chest pain and subsequent risk for myocardial infarction. Neurology 1995;45:2135-2142.
18. Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 1981;304:763-766.
19. Lafitte C, Even C, Henry-Lebras F, de Toffol B, Autret A. Migraine and angina pectoris by coronary artery spasm. Headache 1996;36:332-334.
20. Leon-Sotomayor LA. Cardiac migraine-report of twelve cases. Angiology 1974;25:161-171.
21. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
22. Jackson R, Chambless LE, Yang K, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol 1996;49:1441-1446.
23. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
24. Rose GA. Chest pain questionnaire. Milbank Memorial Fund Q 1965; 43:32-39.
25. LaCroix AZ, Guralnik JM, Curb JD, Wallace RB, Ostfeld AM, Hennekens CH. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation 1990;81:437-446.
26. Sorlie PD, Cooper L, Schreiner PJ, Rosamond W, Szklo M. Repeatability and validity of the Rose Questionnaire for angina pectoris in the Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1996;49: 719-725.
27. National Heart Lung and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study: manual of procedures, no. 5. In: Electrocardiography. Chapel Hill: University of North Carolina at Chapel Hill School of Public Health, ARIC Coordinating Center, 1987.
28. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996;49:223-233.
29. SAS Institute, Inc. Statistical analysis system, version 8.2. Cary, NC: SAS, 1989.
30. Zhao DY. Logistic regression adjustment of proportions and its macro procedure. In: The SAS Users Group International Conference (SUGI) 22, 1998; San Diego, CA, 1998:1045-1050.
31. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157:940-943.
32. Allison P. Poisson regression. In: Logistic regression using SAS. Cary, NC: SAS Institute, 1999.
33. Welch KM. Contemporary concepts of migraine pathogenesis. Neurology 2003;61(suppl 4):S2-S8.
34. O'Keeffe ST, Tsapatsaris NP, Beetham WP Jr. Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med 1992;116:985-989.
35. Bass EB, Follansbee WP, Orchard TJ. Comparison of a supplemented Rose Questionnaire to exercise thallium testing in men and women. J Clin Epidemiol 1989;42:385-394.
36. Garber CE, Carleton RA, Heller GV. Comparison of "Rose Questionnaire Angina" to exercise thallium scintigraphy: different findings in males and females. J Clin Epidemiol 1992;45:715-720.
37. Ruschitzka FT, Noll G, Luscher TF. The endothelium in coronary artery disease. Cardiology 1997;88(suppl 3):3-19.
38. Quyyumi AA, Cannon RO III, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation 1992;86:1864-1871.
39. Stronks DL, Tulen JH, Verheij R, et al. Serotonergic, catecholaminergic, and cardiovascular reactions to mental stress in female migraine patients. A controlled study. Headache 1998;38:270-280.
40. Holm JE, Lamberty K, McSherry WC II, Davis PA. The stress response in headache sufferers: physiological and psychological reactivity. Headache 1997;37:221-227.
41. Nestel PJ, Verghese A, Lovell RR. Catecholamine secretion and sympathetic nervous responses to emotion in men with and without angina pectoris. Am Heart J 1967;73:227-234.
42. Rosano GMC, Kaski JC. Abnormal neurohumoral control in pathogenesis of syndrome X. In: Kaski JC, ed. Angina pectoris with normal coronary arteries: syndrome X. Boston: Kluwer Academic, 1994.
43. Thomsen LL, Iversen HK, Boesen F, Olesen J. Transcranial Doppler and cardiovascular responses during cardiovascular autonomic tests in migraineurs during and outside attacks. Brain 1995;118:1319-1327.
44. Kugiyama K, Ohgushi M, Motoyama T, et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997;30:920-926.
45. Tousoulis D, Davies GJ, Tentolouris C, et al. Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries. Am J Cardiol 1998;82:1110-1113, A1116.
46. Thomsen LL, Olesen J. Nitric oxide theory of migraine. Clin Neurosci 1998;5:28-33.
47. Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991;325:316-321.
48. Kelly KM. Cardiac arrest following use of sumatriptan. Neurology 1995; 45:1211-1213.
49. Carson AL, Rose KM, Sanford CP, et al. Lifetime prevalence of migraine and other headaches lasting 4 or more hours: the Atherosclerosis Risk in Communities (ARIC) Study. Headache 2004;44:20-28.